Weight Loss
Mounjaro®
A once-weekly tirzepatide injection, FDA-approved to improve blood sugar control in adults with type 2 diabetes.
Price is based on patient insurance and pharmacy collection
*Requires a Mochi Health Membership. Cost of medication not included in Mochi Health Membership Fee
Results
Treatment overview
FDA-Approved for Type 2 Diabetes
1
Mounjaro is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Significant A1C Reduction
2
In clinical trials, tirzepatide produced substantial reductions in HbA1c across multiple dose levels.
Dual-Hormone Mechanism
3
Activates both GIP and GLP-1 receptors to enhance glucose-dependent insulin secretion and improve glycemic control.
Once-Weekly Injection
4
A single subcutaneous injection taken once a week, any time of day, with or without food.
Pre-filled Single-Dose Pen
5
Comes in a ready-to-use pen with a pre-attached, hidden needle for straightforward self-administration.
Gradual Dose Titration
6
Starts at a low dose and steps up over time to help your body adjust and minimize gastrointestinal side effects.
The treatment
Understanding the treatment
Active Ingredient:
Tirzepatide
Mounjaro is a once-weekly injectable medication containing tirzepatide, a dual GIP and GLP-1 receptor agonist. It is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Tirzepatide enhances glucose-dependent insulin secretion, suppresses glucagon when glucose is elevated, slows gastric emptying, and reduces appetite. Treatment begins at a low dose and is titrated upward gradually to help your body adjust and reduce gastrointestinal side effects.
Side effects
Most common: nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, decreased appetite, fatigue, and injection-site reactions. Less common but serious: pancreatitis, gallbladder problems, acute kidney injury from dehydration, hypoglycemia (with other diabetes meds), worsening diabetic retinopathy, and rare severe allergic reactions.
Avoid When
Personal or family history of medullary thyroid cancer or MEN 2; history of pancreatitis; severe gastroparesis or other significant GI disease; pregnancy or breastfeeding; known hypersensitivity. Use caution with insulin or sulfonylureas (hypoglycemia), gallbladder disease, kidney disease, or diabetic retinopathy.
Personalized care
The medication is
the smaller part
Mochi pairs you with a physician, care team, pharmacist, and personalized plan designed to support your body, progress, and long-term goals over time.
For iOS & Android
